Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05963204
Other study ID # GLI.04.US.SL.023
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 7, 2023
Est. completion date August 31, 2024

Study information

Verified date June 2023
Source Galderma R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess skin structural change in midface after treatment with a biostimulator using Line-Field Optical Coherence Tomography


Description:

This is a randomized, double-blinded, split-face, comparative study. This study is designed to enroll and randomize approximately 20 subjects. All subjects are to have midface volume loss and contour deficiency and facial photodamage. Eligible subjects are randomized to receive study skincare products for pre-conditioning, 2 weeks before Baseline. All subjects receive biostimulator treatment at the midface by the Treating Investigator at Baseline. The method of injection is at the discretion of the Treating Investigator. A sufficient amount of product is injected to achieve optimal correction of the midface, in the opinion of the Treating Investigator. At the 6-week visit, after all study procedures for the visit are completed, treated subjects received a second biostimulator treatment to achieve optimal aesthetic improvement. At the 12-week and 18-week visits, similar study procedures are performed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 21
Est. completion date August 31, 2024
Est. primary completion date March 19, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: - Subjects diagnosed with symmetrical, moderate-to-severe cheek wrinkles on each side of the face as assessed via the Galderma Cheek Wrinkles Scale. - Subjects with symmetrical, mild-to-severe photodamage at both sides of the midface. - Subject who in the opinion of the treating investigator would need 2 biostimulator treatments for optimal clinical outcomes. - Ability of giving consent for participation in the study. - Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments. Exclusion Criteria: - Subjects with asymmetrical severity or unidentical cheek wrinkle score between 2 sides of the cheek. - Asymmetrical severity photodamage score between 2 sides of the midface. - Subjects with a history of allergy or hypersensitivity to any ingredient of the treatment products. - Previous tissue-augmenting therapy, contouring, or revitalization treatment in the face, except lips. - Previous treatment/procedure in the face in the previous 6 months that, in the Investigator's opinion, would interfere with the study injections and/or study assessments or exposed the study subject to undue risk by study participation, or planning to undergo any of these procedures affecting the treatment area at any time during the study. - Subjects with any medical condition that, in the opinion of the Investigator, would make the subject unsuitable for inclusion.

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Sculptra and Alastin Restorative Skin Complex
Biostimulator and cosmetics
Sculptra and CeraVe Daily Moisturizing Lotion
Biostimulator and cosmetics

Locations

Country Name City State
United States Markowitz Medicals New York New York

Sponsors (1)

Lead Sponsor Collaborator
Galderma R&D

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Structural change in midface post-treatment with a biostimulator compared to pre-treatment Percent change in collagen fiber density using Line-Field Confocal Optical Coherence Tomography at defined timepoints compared to baseline. Collagen density is defined as a number of fibers and is measured on each side of the midface. 6 weeks and 18 weeks after Baseline
Secondary Improvement in clinical grading score compared to pre-treatment Percent change in skin parameters includes photodamage, roughness, radiance at defined timepoints compared to re-treatment. Each parameter is assessed by the Investigator on each side of the face using a 10-point Modified Griffiths' scale where 0 = none and 9 = severe. Baseline, at 6 weeks, 12 weeks, and 18 weeks after Baseline
Secondary Subject satisfaction using a self-assessment questionnaire Survey where subjects are asked about their satisfaction with treatment outcome on each half of their face. A 5-point subject satisfaction questionnaire with the following responses: strongly agree, agree, neither agree nor disagree, disagree, strongly disagree. Baseline, at 6 weeks, 12 weeks, and 18 weeks after Baseline
See also
  Status Clinical Trial Phase
Terminated NCT03573076 - Treatment of Photodamaged Skin of the décolleté Phase 4
Suspended NCT03963102 - Duration of Ameluz Application in Acral Actinic Keratoses Response Phase 4
Completed NCT01283464 - Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles Phase 2
Active, not recruiting NCT06170346 - Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced Phase 2
Completed NCT02736760 - Daylight-PDT With MAL for AK and Photodamaged Skin Phase 4
Active, not recruiting NCT05456334 - New Treatments for Actinic Keratoses of the Scalp N/A
Completed NCT05423873 - A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging N/A
Completed NCT03095872 - Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy Phase 3
Not yet recruiting NCT05908825 - Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults N/A
Recruiting NCT04523961 - Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face Phase 2/Phase 3
Completed NCT01787461 - A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure Phase 4
Recruiting NCT06351358 - Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies N/A
Completed NCT04065035 - A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming N/A
Active, not recruiting NCT04096742 - Altreno for Chest Rejuvenation Phase 4
Completed NCT02693054 - Safety and Efficacy Study for Various Skin Conditions N/A
Terminated NCT00375141 - Long-Pulsed Dye Laser and Intense Pulsed Light for Skin Rejuvenation. N/A